Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger S Lo

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Cell Research|May 9, 2012
Receptor tyrosine kinases in cancer escape from BRAF inhibitorsRoger S Lo
The Journal of Investigative Dermatology|January 16, 2013
Melanoma prognostics and personalized therapeutics at a crossroadRoger S Lo
Pharmacogenomics|January 20, 2012
Combinatorial therapies to overcome B-RAF inhibitor resistance in melanomasRoger S Lo
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Detecting mechanisms of acquired BRAF inhibitor resistance in melanomaRoger S Lo, Hubing Shi
Cancer Discovery|May 3, 2020
Trying for a BRAF Slam DunkAntoni Ribas, Roger S Lo
Cancer Research|June 4, 2008
Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytesRoger S Lo, Owen N Witte
Cancer Research|August 2, 2011
Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibitionHubing Shi, Xiangju Kong, Antoni Ribas, et al.
The Journal of Experimental Medicine|December 11, 2020
SPRED1 deletion confers resistance to MAPK inhibition in melanomaJulien Ablain, Sixue Liu, Gatien Moriceau, et al.
Cancer Discovery|May 31, 2022
Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired ResistanceZhentao Yang, Yan Wang, Sixue Liu, et al.
Cancer Discovery|September 20, 2017
Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant MelanomaAayoung Hong, Gatien Moriceau, Lu Sun, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Cell Research|May 9, 2012
Receptor tyrosine kinases in cancer escape from BRAF inhibitorsRoger S Lo
The Journal of Investigative Dermatology|January 16, 2013
Melanoma prognostics and personalized therapeutics at a crossroadRoger S Lo
Pharmacogenomics|January 20, 2012
Combinatorial therapies to overcome B-RAF inhibitor resistance in melanomasRoger S Lo
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Detecting mechanisms of acquired BRAF inhibitor resistance in melanomaRoger S Lo, Hubing Shi
Cancer Discovery|May 3, 2020
Trying for a BRAF Slam DunkAntoni Ribas, Roger S Lo
Cancer Research|June 4, 2008
Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytesRoger S Lo, Owen N Witte
Cancer Research|August 2, 2011
Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibitionHubing Shi, Xiangju Kong, Antoni Ribas, et al.
The Journal of Experimental Medicine|December 11, 2020
SPRED1 deletion confers resistance to MAPK inhibition in melanomaJulien Ablain, Sixue Liu, Gatien Moriceau, et al.
Cancer Discovery|May 31, 2022
Enhancing PD-L1 Degradation by ITCH during MAPK Inhibitor Therapy Suppresses Acquired ResistanceZhentao Yang, Yan Wang, Sixue Liu, et al.
Cancer Discovery|September 20, 2017
Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant MelanomaAayoung Hong, Gatien Moriceau, Lu Sun, et al.
Pageof 9